Terazosin HCl |
Catalog No.GC13993 |
Le chlorhydrate de térazosine est un dérivé de la quinazoline et un antagoniste des récepteurs α1-adrénergiques compétitif et actif par voie orale.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 70024-40-7
Sample solution is provided at 25 µL, 10mM.
Terazosin Hydrochloride dihydrate is a selective alpha1-antagonist used for treatment of symptoms of benign prostatic hyperplasia (BPH).Target: Alpha-1 Adrenergic ReceptorTerazosin Hydrochloride dihydrate is an a1-selective blocker. Its inhibitory effect on prostate tumor growth may be the result of antiangiogenic activity. Terazosin Hydrochloride dihydrate is an inhibitor of α1A-AR, α1B-AR, α1D-AR and α2B-AR [1].
References:
[1]. Kyncl, J.J., Pharmacology of terazosin: an alpha 1-selective blocker. J Clin Pharmacol, 1993. 33(9): p. 878-83.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *